118 related articles for article (PubMed ID: 1568292)
1. Clinical pharmacokinetics of mitoxantrone after intraperitoneal administration.
Nagel JD; Varossieau FJ; Dubbelman R; ten Bokkel Huinink WW; McVie JG
Cancer Chemother Pharmacol; 1992; 29(6):480-4. PubMed ID: 1568292
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of icodextrin in peritoneal dialysis patients.
Moberly JB; Mujais S; Gehr T; Hamburger R; Sprague S; Kucharski A; Reynolds R; Ogrinc F; Martis L; Wolfson M
Kidney Int Suppl; 2002 Oct; (81):S23-33. PubMed ID: 12230479
[TBL] [Abstract][Full Text] [Related]
3. Feasibility and pharmacokinetics of intraperitoneal suramin in advanced malignancy.
Westermann AM; Dubbelman R; Baars JP; Moolenaar WH; Beijnen JH; Rodenhuis S
Cancer Chemother Pharmacol; 2000; 46(1):57-62. PubMed ID: 10912579
[TBL] [Abstract][Full Text] [Related]
4. Phase I trial of intraperitoneal docetaxel in the treatment of advanced malignancies primarily confined to the peritoneal cavity: dose-limiting toxicity and pharmacokinetics.
Morgan RJ; Doroshow JH; Synold T; Lim D; Shibata S; Margolin K; Schwarz R; Leong L; Somlo G; Twardowski P; Yen Y; Chow W; Lin P; Paz B; Chu D; Frankel P; Stalter S
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5896-901. PubMed ID: 14676112
[TBL] [Abstract][Full Text] [Related]
5. Phase I/II study of intraperitoneal mitoxantrone in refractory ovarian cancer.
Oza AM; ten Bokkel Huinink W; Dubbelman R; Soepenberg O; Mandjes I; Aartsen E; McVie JG
Ann Oncol; 1994 Apr; 5(4):343-7. PubMed ID: 8075031
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer.
Nicoletto MO; Padrini R; Galeotti F; Ferrazzi E; Cartei G; Riddi F; Palumbo M; De Paoli M; Corsini A
Cancer Chemother Pharmacol; 2000; 45(6):457-62. PubMed ID: 10854132
[TBL] [Abstract][Full Text] [Related]
7. Phase I clinical and pharmacological study of intraperitoneal cis-bis-neodecanoato( trans- R, R-1, 2-diaminocyclohexane)-platinum II entrapped in multilamellar liposome vesicles.
Verschraegen CF; Kumagai S; Davidson R; Feig B; Mansfield P; Lee SJ; Maclean DS; Hu W; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Oct; 129(10):549-55. PubMed ID: 14513369
[TBL] [Abstract][Full Text] [Related]
8. Escalating dose regimen of intraperitoneal mitoxantrone: phase I study--clinical and pharmacokinetic evaluation.
Blöchl-Daum B; Eichler HG; Rainer H; Jakesz R; Salzer H; Steger G; Schüller J; Günther E; Proksch B; Ehninger G
Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1133-8. PubMed ID: 3416898
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of intravenous and intraperitoneal ceftriaxone in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vinçon G; Couzineau M; Wone C
Eur J Clin Pharmacol; 1986; 31(4):479-83. PubMed ID: 3816928
[TBL] [Abstract][Full Text] [Related]
10. Phase I study of intraperitoneal recombinant human interleukin 12 in patients with Müllerian carcinoma, gastrointestinal primary malignancies, and mesothelioma.
Lenzi R; Rosenblum M; Verschraegen C; Kudelka AP; Kavanagh JJ; Hicks ME; Lang EA; Nash MA; Levy LB; Garcia ME; Platsoucas CD; Abbruzzese JL; Freedman RS
Clin Cancer Res; 2002 Dec; 8(12):3686-95. PubMed ID: 12473577
[TBL] [Abstract][Full Text] [Related]
11. Intraperitoneal mitoxantrone: a feasibility and pharmacokinetic study.
Civalleri D; Vannozzi MO; De Cian F; Lunardi G; Steinweg M; Pastrone I; Viale M; Esposito M
Eur J Surg Oncol; 2002 Mar; 28(2):172-9. PubMed ID: 11884053
[TBL] [Abstract][Full Text] [Related]
12. Plasma and cellular pharmacokinetics of mitoxantrone in high-dose chemotherapeutic regimen for refractory lymphomas.
Canal P; Attal M; Chatelut E; Guichard S; Huguet F; Muller C; Schlaifer D; Laurent G; Houin G; Bugat R
Cancer Res; 1993 Oct; 53(20):4850-4. PubMed ID: 8402672
[TBL] [Abstract][Full Text] [Related]
13. Phase I clinical and pharmacokinetic study of mitoxantrone given to patients by intraperitoneal administration.
Alberts DS; Surwit EA; Peng YM; McCloskey T; Rivest R; Graham V; McDonald L; Roe D
Cancer Res; 1988 Oct; 48(20):5874-7. PubMed ID: 3167842
[TBL] [Abstract][Full Text] [Related]
14. Phase-I study of intraperitoneal mitoxantrone--clinical and pharmacokinetic evaluation.
Blöchl-Daum B; Eichler HG; Rainer H; Jakesz R; Salzer H; Steger G; Schüller J; Günther E; Proksch P; Ehninger G
Onkologie; 1987 Feb; 10(1):54-6. PubMed ID: 3295627
[TBL] [Abstract][Full Text] [Related]
15. High-dose cyclophosphamide or melphalan with escalating doses of mitoxantrone and autologous bone marrow transplantation for refractory solid tumors.
Mulder PO; Sleijfer DT; Willemse PH; de Vries EG; Uges DR; Mulder NH
Cancer Res; 1989 Aug; 49(16):4654-8. PubMed ID: 2545349
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intraperitoneal teicoplanin in patients with chronic renal failure on continuous ambulatory peritoneal dialysis.
Bonati M; Traina GL; Gentile MG; Fellin G; Rosina R; Cavenaghi L; Buniva G
Br J Clin Pharmacol; 1988 Jun; 25(6):761-5. PubMed ID: 2974299
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of mitoxantrone in humans following single-agent infusion or intra-arterial injection therapy or combined-agent infusion therapy.
Van Belle SJ; de Planque MM; Smith IE; van Oosterom AT; Schoemaker TJ; Deneve W; McVie JG
Cancer Chemother Pharmacol; 1986; 18(1):27-32. PubMed ID: 3757156
[TBL] [Abstract][Full Text] [Related]
18. New aspects on the pharmacokinetics of mitoxantrone and its two major metabolites.
Schleyer E; Kamischke A; Kaufmann CC; Unterhalt M; Hiddemann W
Leukemia; 1994 Mar; 8(3):435-40. PubMed ID: 8127148
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of mitoxantrone in patients after 2 h and 24 h intra-arterial administration.
Czejka MJ; Jäger W; Georgopoulos A; Schüller J
Eur J Drug Metab Pharmacokinet; 1990; 15(3):219-22. PubMed ID: 2253652
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of intravenous and intraperitoneal moxalactam in chronic ambulatory peritoneal dialysis.
Albin H; Ragnaud JM; Demotes-Mainard F; Vincon G; Wone C
Eur J Clin Pharmacol; 1986; 30(3):299-302. PubMed ID: 3732364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
